Paul Knoepfler is an unlikely watchdog for the therapeutic stem cell industry. His University of California, Davis, lab mostly uses stem cells to study cancer-causing gene mutations—not to develop potential therapies. But thanks to The Niche, a blog he has run since 2010, Knoepfler has become an international authority—and a dogged voice of caution—on the clinical use of stem cells. For years, he has sounded the alarm on hundreds of U.S. physicians and clinics advertising stem cells to treat everything from sore knees to spinal cord injury without oversight from the U.S. Food and Drug Administration or support from randomized clinical trials. The blog, which now averages more than 4000 daily visits, has elevated him from an obscure bench scientist into a divisive figure.
Want To Publish your Group Article?
Click HERE to send us your group Article for publishing on our website.
- alzheimer Alzheimers Disease animal model Bacteria Brain breast cancer cancer cell & molecular biology cell-signaling clinical trials CRISPR CRISPR/Cas diabetes disease/medicine DNA drug drug development drug research Gene Expression general health Gene therapy Genetics genetics & genomics Genomics HIV immunology immunotherapy infectious disease Malaria metastasis microbiology microbiome mutation neuroscience new therapy obesity stem cells T cells techniques therapy treatment tumor vaccine virology virus